Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
245 studies found for:    Northwestern AND Liver Disorders
Show Display Options
Rank Status Study
1 Completed Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies
Condition: End Stage Liver Disease
Intervention: Procedure: Leukapheresis
2 Completed Alcohol Biomarkers in Post-Liver Transplant Patients
Condition: Alcohol-related Liver Disease
Intervention:
3 Terminated Total Parenteral Nutrition-Associated Liver Disease
Condition: Liver Diseases
Intervention: Drug: Choline Chloride
4 Enrolling by invitation Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease
Conditions: Liver Disease;   Cardiovascular Disease
Intervention: Drug: Cholate testing
5 Completed
Has Results
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
Conditions: Nonalcoholic Steatohepatitis;   Liver Diseases
Interventions: Drug: Pentoxifylline;   Drug: Placebo
6 Completed
Has Results
HRQoL in the Low MELD Pre-tx Population
Condition: Cirrhosis of the Liver
Intervention:
7 Completed Protocol for the Assessment of Variability in Histology and Gene Expression in Bariatric Surgery Patients.
Condition: Obesity
Intervention:
8 Unknown  A Trial of Taurine Supplementation in Parenteral Nutrition 1
Condition: Cholestasis
Intervention: Procedure: intravenous taurine in nutritional supplement
9 Active, not recruiting A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
Conditions: Liver Diseases;   Hepatocellular Cancer;   Endstage Liver Disease;   Liver Cirrhosis
Intervention: Behavioral: donor pain management/ Pre-operative OR Set-up
10 Completed Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation
Conditions: Obesity;   Cardiovascular Disease;   Type 2 Diabetes;   Hypertension;   Complication of Transplant
Intervention: Procedure: Sleeve Gastrectomy
11 Completed
Has Results
Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates
Condition: Parenteral Nutrition-Associated Liver Disease
Interventions: Other: Intravenous fat emulsion;   Other: Restriction of intravenous fat emulsion to 1 gm/kg/d
12 Terminated
Has Results
Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI
Conditions: Chronic Liver Disease;   Hepatocellular Carcinoma (HCC)
Intervention: Drug: 13C Sodium Octanoate
13 Active, not recruiting The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
Condition: NAFLD
Interventions: Drug: Sildenafil 1.0 mg;   Drug: Metformin;   Drug: Leucine;   Drug: Placebo;   Drug: Sildenafil Citrate 0.5 mg
14 Recruiting Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Conditions: Liver Transplant;   Hepatitis C;   Chronic Kidney Disease;   Acute Rejection
Intervention:
15 Not yet recruiting Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
Condition: Cirrhosis
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Drug: Simvastatin
16 Completed
Has Results
Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
Conditions: HIV Infections;   Hepatitis C;   Liver Disease
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin
17 Recruiting Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)
Condition: Liver Cancer
Intervention: Procedure: Blood draw
18 Completed Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy
Condition: Hepatitis B
Intervention: Drug: Anti-HBV nucleoside/nucleotide therapy
19 Recruiting Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
Conditions: Thrombocytopenia;   Cirrhosis
Intervention: Device: TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
20 Completed
Has Results
Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
Conditions: End Stage Liver Disease;   Hepatitis C
Interventions: Drug: Daclizumub;   Drug: Tacrolimus;   Drug: Cyclosporine;   Drug: MMF

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.